Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PFE compared with SKT: revenue, margins and what each company keeps, and the suppliers and customers both name
PFE
Pfizer Inc
Change
Mkt cap
Revenue
Revenue
SKT
Tanger Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
PFE
Pfizer Inc
vs
SKT
Tanger Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only PFE
34
MIRM
Mirum Pharmaceuticals
customer
ICUI
ICU Medical
customer
BEAM
Beam Therapeutics
supplier
ADPT
Adaptive Biotechnologies
supplier
30 more · PFE chain
›
Shared
0
No shared counterparties.
Only SKT
2
—
Northline Indemnity
unlisted
supplier
—
Tanger Properties Limited Partnership
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
PFE
Pfizer Inc
Change
29.39
▼
−0.21%
· post 29.35
Mkt cap
$167.5B
Revenue
$16.6B
Q3 FY26
Revenue
$62.6B
FY25
SKT
Tanger Inc.
Change
38.68
▲
+0.74%
· post 38.68
Closed
Nov 6 '26
Mkt cap
$4.4B
Revenue
$156M
Q2 FY26
Revenue
$1.7B
FY25
vs
Compare
Closed
Nov 6 '26
PFE
Pfizer Inc
vs
SKT
Tanger Inc.
29.39
▼
−0.21%
post 29.35
Price
38.68
▲
+0.74%
post 38.68
$167.5B
Mkt cap
$4.4B
Q3 FY26
$16.6B
Revenue
$156M
Q2 FY26
FY25
$62.6B
Revenue
$1.7B
FY25
Change
Change
PFE
29.39
▼
−0.21%
vs
SKT
38.68
▲
+0.74%
Closed
Nov 6 '26